Facebook
Twitter
Telegram
Report an ErrorPandion Therapeutics, Inc. Financial Statements 2011-2024 | PAND
Annual Financial Statements Pandion Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
419 M | - | - | - | - | - | - | - | - | - |
Shares |
23.3 M | - | - | - | - | - | - | - | - | - |
Net Income |
-38.1 M | -21.9 M | -10.9 M | - | - | - | - | - | - | - |
Revenue |
8.78 M | 967 K | - | - | - | - | - | - | - | - |
EBITDA |
-37.4 M | -22 M | -11 M | - | - | - | - | - | - | - |
Operating Expenses |
46.7 M | 23.2 M | 11 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.8 M | 5.01 M | 2.66 M | - | - | - | - | - | - | - |
All numbers in USD currency